Hologic (HOLX:NASDAQ) Annual Reports & Investor Relations Material

Overview

Medical technology company Hologic, Inc. is making strides in women's health through its development, manufacture, and supply of diagnostics, medical imaging systems, and surgical products. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health, offering a variety of products for early detection and treatment. Hologic's diagnostics include Aptima molecular diagnostic assays for infectious microorganisms and Aptima viral load assays for various viruses, while its breast cancer care solutions encompass 2D and 3D digital mammography systems, ultrasound imaging, and breast conserving surgery products. The company also provides treatments for abnormal uterine bleeding, minimally invasive orthopedic surgical procedures, and more, with products sold through both direct sales and independent distributors. Headquartered in Marlborough, Massachusetts, Hologic was incorporated in 1985.

Frequently Asked Questions

What is Hologic's ticker?

Hologic's ticker is HOLX

What exchange is Hologic traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Hologic's headquarters?

They are based in Marlborough, Massachusetts

How many employees does Hologic have?

There are 5001-10,000 employees working at Hologic

What is Hologic's website?

It is hologic.com

What type of sector is Hologic?

Hologic is in the Healthcare sector

What type of industry is Hologic?

Hologic is in the Medical Appliances & Equipment industry

Who are Hologic's peers and competitors?

The following five companies are Hologic's industry peers:

- Smith & Nephew

- Stereotaxis

- AdaptHealth

- STRATA Skin Sciences

- Adaptimmune Therapeutics